Skip to content

Effect Of Jambu Beej Churna in Asthibhagna (fractures)

A Randomised Controlled Clinical Trial To study The Effect Of Jambu Beej Churna In The Management of Asthibhagna With Special Reference To Closed Un-displaced Fractures - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086694
Enrollment
70
Registered
2025-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M843- Stress fracture

Interventions

None listed

Sponsors

Dr Ashwini Kiran Walinjkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between 18 to 50 years old will be selected. 2) Patients will be selected Irrespective of caste, religion, gender and socioeconomic status. 3) Patients with closed undisplaced fractures will be Included.

Exclusion criteria

Exclusion criteria: 1) Patients other than closed un-displaced fractures are excluded. 2) Patients with known case of Diabetes Mellitus, Hypertension will be excluded. 3) Patients with pathological fracture like osteoporosis will excluded. 4) Fractures that require open reduction and internal fixation. 5) Patients with a history of previous nonunion, metastatic tumour will be excluded.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of Asthibhagna after ingestion of Jambu beej churnaTimepoint: 25 days

Secondary

MeasureTime frame
Where the trial group stands in comparison with control groupTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Ashwini Kiran Walinjkar

SMBT Ayurved college and Hospital

drdkumavat@gmail.com9049059799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026